Establishment of a bioluminescent Renca cell line for renal carcinoma research

[1]  R. Nolley,et al.  Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation , 2017, Cancer biology & therapy.

[2]  M. Zollo,et al.  In vivo bioluminescence imaging using orthotopic xenografts towards patient's derived-xenograft Medulloblastoma models. , 2017, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[3]  P. Houghton,et al.  Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALL , 2017, Clinical Cancer Research.

[4]  N. Tamaki,et al.  Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft , 2016, EJNMMI Research.

[5]  K. Gardner,et al.  Targeting renal cell carcinoma with a HIF-2 antagonist , 2016, Nature.

[6]  Zhen Zhao,et al.  Bioluminescence imaging of transplanted human endothelial colony-forming cells in an ischemic mouse model , 2016, Brain Research.

[7]  M. Lythgoe,et al.  Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence , 2016, PloS one.

[8]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[9]  J. Fei,et al.  Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. , 2015, Biomaterials.

[10]  Wanqing Chen,et al.  Cancer statistics: updated cancer burden in China. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[11]  Yuman Fong,et al.  Bioluminescence Imaging Serves as a Dynamic Marker for Guiding and Assessing Thermal Treatment of Cancer in a Preclinical Model , 2012, Annals of Surgical Oncology.

[12]  B. Escudier.  Chemo-immunotherapy in RCC: the end of a story , 2010, The Lancet.

[13]  C. Charbonneau,et al.  Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. , 2008, Cancer treatment reviews.

[14]  G. Gasparini,et al.  Integrated therapy of kidney cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  Mark A Rosen,et al.  Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference , 2007, Clinical Cancer Research.

[16]  W. Jia,et al.  EXPRESSION OF HUMAN FACTOR IX GENE IN MURINE PLASMA THROUGH LENTIVIRAL VECTOR‐INFECTED HAEMATOPOIETIC STEM CELLS , 2006, Clinical and experimental pharmacology & physiology.

[17]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. , 2003, Cancer research.

[18]  A. Kiderlen,et al.  A highly sensitive cytotoxicity assay based on the release of reporter enzymes, from stably transfected cell lines. , 1997, Journal of immunological methods.

[19]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[20]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[21]  Zhen Zhao,et al.  Dual-reporter Imaging and its Potential Application in Tracking Studies , 2015, Journal of Fluorescence.

[22]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.